Clinical Observations on the Use of New Anti-Vegf Drug, Conbercept, in Age-Related Macular Degeneration Therapy: A Meta-Analysis

Clinical Interventions in Aging - New Zealand
doi 10.2147/cia.s151225
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Genetic Biomarkers in the VEGF Pathway Predicting Response to Anti-Vegf Therapy in Age-Related Macular Degeneration

BMJ Open Ophthalmology
Ophthalmology
2019English

Recovery of Photoreceptor Outer Segments After Anti-Vegf Therapy for Age-Related Macular Degeneration

Graefe's Archive for Clinical and Experimental Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2012English

Conbercept for Patients With Age-Related Macular Degeneration: A Systematic Review

BMC Ophthalmology
MedicineOphthalmology
2018English

New Drug Approved for Age Related Macular Degeneration

BMJ
2007English

Common Variant in VEGFA and Response to Anti-Vegf Therapy for Neovascular Age-Related Macular Degeneration

Current Molecular Medicine
BiochemistryMedicineMolecular MedicineMolecular Biology
2013English

Profile of Conbercept in the Treatment Of neovascular Age-Related Macular Degeneration

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Age-Related Macular Degeneration and Anti-Aging

Drug Delivery System
Pharmaceutical Science
2009English

Long-Lasting Effects of Anti-Vegf/Photodynamic Combination Therapy in the Treatment of Exudative Age-Related Macular Degeneration: A Retrospective Chart Review

Clinical Ophthalmology
Ophthalmology
2014English

Photodynamic Therapy for Age-Related Macular Degeneration

The Review of Laser Engineering
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy